# Sanofi: portfolio, investments and team > Sanofi is an investment firm based in France. 96 investments on record, 27 in the last 12 months, latest Aug 2026. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/sanofi (Millionrounds; every figure on the page links to its filing or article) France · [Investor](https://millionrounds.com/investors) # Sanofi Last cheque observed Aug 2026; 96 cheques on record. Deploying now Investment firm Series B Venture Series A Biotechnology Health Care Deploying now **79%** of best year **27** **cheques in 12 months**, 96 on record Since the last cheque **86** days **00** hrs **00** min **00** sec Median round **$60M** Rounds led **1 of 96** Sole investor **8 rounds** Exits **1 from the portfolio** Mostly in **United States, 74%** Pitch Sanofi ## Sanofi highlights - 01 27 cheques in the last 12 months - 02 Mostly Series B and Venture: 59% of its rounds - 03 Sole investor in 8 rounds, median $25M - 04 1 exits from the portfolio ## What they do - **Type:** Investment firm (from a list, unverified) - **Cheque size:** Not stated - **Sectors:** Biotechnology Health Care - **Based in:** France - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **96 appearances** - **2026** 22 rounds - **Aug** **[MapLight Therapeutics](https://millionrounds.com/company/maplight-therapeutics)** US **$150M** With 2 others - **Aug** **[Epicrispr Biotechnologies](https://millionrounds.com/company/epicrispr-biotechnologies)** Series C · US **$90M** With 3 others - **Jul** **[Scribe Therapeutics](https://millionrounds.com/company/scribe-therapeutics)** US **$7.5M** With 4 others - **Jul** **[Q32 Bio](https://millionrounds.com/company/q32-bio)** US **$200M** With 2 others - **Jul** **[MeiraGTx](https://millionrounds.com/company/meiragtx)** Debt · US **$125M** With 2 others - **Jun** **[Bionyra Pharma](https://millionrounds.com/company/bionyra-pharma)** Series A · FR · Ventureburn **$165M** With 7 others - **Jun** **[COUR Pharma](https://millionrounds.com/company/cour-pharma)** Series B · US · Lumira Ventures **$50M** With 7 others - **Jun** **[Memento Medicines](https://millionrounds.com/company/memento-medicines)** Series A · GB **$93M** With 3 others - **Jun** **[Nura Bio](https://millionrounds.com/company/nura-bio)** Series B · US **$74M** With 1 other - **May** **[BranchLab](https://millionrounds.com/company/branchlab)** Series A · US · TechStartups **$26M** With 4 others - **May** **[Click Therapeutics](https://millionrounds.com/company/click-therapeutics)** Series D · US · Revelation Partners **$50M** With 3 others - **Mar** **[Waiv](https://millionrounds.com/company/waiv)** FR · Ventureburn **$33M** With 8 others - **Mar** **[Earendil Labs](https://millionrounds.com/company/earendil-labs)** Venture · US **$787M** With 1 other - **Mar** **[SAB Biotherapeutics](https://millionrounds.com/company/sab-biotherapeutics)** US **$85M** With 3 others - **Feb** **[Alveus Therapeutics Inc.](https://millionrounds.com/company/alveus-therapeutics-inc)** Series A · US · Seroba Life Sciences **$197M** With 8 others - **Feb** **[QuantX Biosciences](https://millionrounds.com/company/quantx-biosciences)** Series B · US **$85M** With 3 others - **Feb** **[GluBio Therapeutics](https://millionrounds.com/company/glubio-therapeutics)** Venture **$30M** With 4 others - **Feb** **[Altesa](https://millionrounds.com/company/altesa)** Series B · US **$75M** With 2 others - **Jan** **[InduPro](https://millionrounds.com/company/indupro)** Venture · US **Undisclosed** With 1 other - **Jan** **[Enable Injections](https://millionrounds.com/company/enable-injections)** Venture · US **$30M** With 2 others - **Jan** **[Mirador Therapeutics](https://millionrounds.com/company/mirador-therapeutics)** Series B · US **$250M** With 6 others - **Jan** **[Muna Therapeutics](https://millionrounds.com/company/muna-therapeutics)** Grant · DK **$1.0M** With 3 others - **2025** 29 rounds - **Dec** **[Rology](https://millionrounds.com/company/rology)** Growth · EG · Disrupt Africa **Undisclosed** With 5 others - **Dec** **[Fulcrum Therapeutics](https://millionrounds.com/company/fulcrum-therapeutics)** US **$175M** With 4 others - **Nov** **[T-Therapeutics](https://millionrounds.com/company/t-therapeutics)** Series A · GB · Silicon Canals **$32M** With 4 others - **Nov** **[Lifordi Immunotherapeutics](https://millionrounds.com/company/lifordi-immunotherapeutics)** Venture · US **$42M** With 3 others - **Nov** **[Imbria Pharmaceuticals](https://millionrounds.com/company/imbria-pharmaceuticals)** Venture · US **Undisclosed** With 3 others - **Oct** **[Expedition Therapeutics](https://millionrounds.com/company/expedition-therapeutics)** Series A · US **$165M** With 3 others - **Oct** **[Zag Bio](https://millionrounds.com/company/zag-bio)** Series A · US · Firms' own news pages **$80M** With 9 others - **Oct** **[Electra Therapeutics](https://millionrounds.com/company/electra-therapeutics)** Series C · US **$183M** With 4 others - **Oct** **QuantHealth** Venture · IL **Undisclosed** With 1 other - **Sept** **[ReCode Therapeutics](https://millionrounds.com/company/recode-therapeutics)** Debt · US **$29M** With 1 other - **Sept** **[Character Biosciences](https://millionrounds.com/company/character-biosciences)** Series B · US **$17M** With 4 others - **Sept** **[Enveda](https://millionrounds.com/company/enveda)** Series D · US **$150M** With 4 others - **Jul** **[MapLight Therapeutics](https://millionrounds.com/company/maplight-therapeutics)** Series D · US **$373M** With 3 others - **Jul** **[Kasha](https://millionrounds.com/company/kasha)** Venture · US **Undisclosed** With 1 other - **Jul** **[Adagene](https://millionrounds.com/company/adagene)** **$25M** With 3 others - **Jun** **[Splice Bio](https://millionrounds.com/company/splice-bio)** Series B · ES **$135M** With 2 others - **May** **[Eligo Bioscience](https://millionrounds.com/company/eligo-bioscience)** Grant · FR **$5.0M** With 3 others - **May** **[Zucara Therapeutics](https://millionrounds.com/company/zucara-therapeutics)** Series B · CA **$5.0M** With 3 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **47** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **5+** funds on file numbered funds in its name ## Exits from the portfolio Companies it backed that were later bought or listed **1 in all** **[Lumena Pharmaceuticals](https://millionrounds.com/company/lumena-pharmaceuticals)** Bought by [Shire](https://millionrounds.com/fund/shire) **$260M** May 2014 An exit counts when it came after the firm's first round in the company. From historical deal records. ## Companies it bought Acquisitions by the firm itself **Elder Pharamaceuticals** **$351M** Nov 2013 **[Pluromed](https://millionrounds.com/company/pluromed)** **Undisclosed** Mar 2012 **Genzyme** **$20B** Feb 2011 **[TargeGen](https://millionrounds.com/company/targegen)** **$635M** Jun 2010 **[Fovea Pharmaceuticals](https://millionrounds.com/company/fovea-pharmaceuticals)** **Undisclosed** Oct 2009 **Shantha Biotechnics** **$770M** Jul 2009 **Merial Limited** **$4.0B** Jul 2009 **[BiPar Sciences](https://millionrounds.com/company/bipar-sciences)** **$500M** Apr 2009 ## The cheque Series B Venture Series A Median round joined **$60M** the round, not its cheque Alone, median **$25M** Led 1 of 96 rounds **1%** - **Sole investor:** 8 rounds - **Last cheque:** Aug 2026 - **Exits:** 1 from the portfolio Rounds by stage said on their site - Series B *22* - Venture *20* - Series A *17* - Series C *7* - Series D *5* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) 14 - [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) 7 - [Novo Holdings](https://millionrounds.com/fund/novo-ventures) 7 - [5AM Ventures](https://millionrounds.com/fund/5am-ventures) 6 - [Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) 6 - [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 6 **Pitching Sanofi?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Sanofi. A count of rooms they were both in, not a relationship either has claimed. [**RA Capital Management** Private equity **14** rounds together](https://millionrounds.com/fund/ra-capital-management)[**Cormorant Asset Management** Private equity **7** rounds together](https://millionrounds.com/fund/cormorant-asset-management)[**Novo Holdings** VC firm **7** rounds together](https://millionrounds.com/fund/novo-ventures)[**5AM Ventures** VC firm **6** rounds together](https://millionrounds.com/fund/5am-ventures)[**Forbion Capital Partners** Private equity **6** rounds together](https://millionrounds.com/fund/forbion-capital-partners)[**New Enterprise Associates** VC firm **6** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**ARCH Venture Partners** VC firm **5** rounds together](https://millionrounds.com/fund/arch-venture-partners)[**Blue Owl** Asset manager **5** rounds together](https://millionrounds.com/fund/blue-owl)[**OrbiMed** Private equity **5** rounds together](https://millionrounds.com/fund/orbimed)[**Alexandria Venture Investments** VC firm **4** rounds together](https://millionrounds.com/fund/alexandria-venture-investments)[**Atlas Venture** VC firm **4** rounds together](https://millionrounds.com/fund/atlas-venture)[**Catalio Capital Management** VC firm **4** rounds together](https://millionrounds.com/fund/catalio-capital-management) ## Recently backed The latest companies Sanofi put money into. [**MapLight Therapeutics** $150M · Aug 2026](https://millionrounds.com/company/maplight-therapeutics)[**Epicrispr Biotechnologies** $90M · Aug 2026](https://millionrounds.com/company/epicrispr-biotechnologies)[**Scribe Therapeutics** $7.5M · Jul 2026](https://millionrounds.com/company/scribe-therapeutics)[**Q32 Bio** $200M · Jul 2026](https://millionrounds.com/company/q32-bio)[**COUR Pharma** $50M · Jun 2026](https://millionrounds.com/company/cour-pharma)[**Nura Bio** $74M · Jun 2026](https://millionrounds.com/company/nura-bio) ## Quick answers about Sanofi ### What does Sanofi invest in? Sanofi invests most often at Series B and Venture (59% of the rounds on record), in sectors such as Biotechnology and Health Care. ### How active is Sanofi? 96 investments on record, 27 of them in the last 12 months, and it led 1. The most recent was in Aug 2026. ### What has Sanofi invested in recently? Its most recent investments on record: MapLight Therapeutics (Undisclosed round, Aug 2026), Epicrispr Biotechnologies (Series C, Aug 2026) and Scribe Therapeutics (Undisclosed round, Jul 2026). ### How big are Sanofi's cheques? The median round it joins is $60M. ### Does Sanofi lead rounds? Sometimes: it led 1 of its 96 investments on record (1%). ### Where does Sanofi invest? Most of the companies it backs are in the United States (74%), France (8%) and the United Kingdom (5%). ### Is Sanofi investing now? Yes: it is actively investing, with 27 investments in the last 12 months. ### Who does Sanofi invest alongside? Most often RA Capital Management (14 rounds together), Cormorant Asset Management (7 rounds together) and Novo Holdings (7 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=sanofi) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=sanofi)